MStranslate logo
Log In
Lost your password?
Lost Password
Back to login
Search
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us
Breaking
  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast - Episode Library
  • Patient Community Day at ECTRIMS 2025
  • Multiple Sclerosis in 2025 – Key Developments to Date
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us

Research

Home
Research
ACTRIMS Forum 2021

ACTRIMS Forum 2021 – Virtual Meeting Coverage

MStranslate
February 28, 2021
ACTRIMS, Conferences, Hormones, Research, Videos
In 2021, the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum was set to take place in Phoenix, Arizona, between February 25th to 27th.  However, due to the coronavirus...
gut microbiome

The Gut Microbiome In MS – New Research

MStranslate
February 23, 2021
Research
A study from researchers at the University Medical Center of the Johannes Gutenberg-University Mainz has found a new potential link between the immune system and the gut microbiome in an animal model of...
childhood trauma

Childhood Trauma & Multiple Sclerosis: A Study Overview

MStranslate
February 16, 2021
Research
In this video, our co-founder, Brett Drummond, summarises a recently published study by University of Illinois at Urbana-Champaign researchers, where they used an animal model to investigate how childhood...
mRNA vaccines

mRNA Vaccines & Their Potential in MS

MStranslate
January 15, 2021
Research, Treatments, Videos
Recently published research from the University Medical Center of the Johannes Gutenberg University has looked at the use of an mRNA vaccine as a potential treatment for multiple sclerosis. In this below...
cannabis oils

Cannabis Oils & Pomegranate Peel Extract

MStranslate
January 6, 2021
Research, Treatments
Happy New Year everyone!  We hope that 2021 is a fantastic year and that we see lots of positive developments in the field of multiple sclerosis research.  For the first time last year, we trialled an...
research update

Multiple Sclerosis Research Update – December 2020

MStranslate
December 15, 2020
Progressive MS, Research, Stem Cells, Treatments
With the end of 2020 approaching (I don’t think anyone is going to miss it), we thought we would try out a new style of research update.  Generally, our articles are an in-depth look at a specific study...
MS Virtual 2020

MS Virtual 2020: An In-depth Interview Series

MStranslate
October 29, 2020
Conferences, MS Virtual, Q&A, Research
1 Comment
As our daily coverage of MS Virtual 2020 demonstrated, there we many fascinating presentations delivered across the three days of the conference, covering a vast spectrum of multiple sclerosis research topics...
MS Virtual 2020

MS Virtual 2020: Review of Our Day 3 Coverage

MStranslate
September 23, 2020
Conferences, MS Virtual, Research
Due to the coronavirus pandemic, this year’s joint ACTRIMS-ECTRIMS Congress, which was meant to take place in Washington DC, became MS Virtual 2020, a conference conducted entirely online. We are pleased...
MS Virtual 2020

MS Virtual 2020: Review of Our Day 2 Coverage

MStranslate
September 18, 2020
Conferences, MS Virtual, Research
1 Comment
Due to the coronavirus pandemic, this year’s joint ACTRIMS-ECTRIMS Congress, which was meant to take place in Washington DC, became MS Virtual 2020, a conference conducted entirely online. We are pleased...
MS Virtual 2020

MS Virtual 2020: Review of Our Day 1 Coverage

MStranslate
September 14, 2020
Conferences, MS Virtual, Research
2 Comments
Due to the coronavirus pandemic, this year's joint ACTRIMS-ECTRIMS Congress, which was meant to take place in Washington DC, became MS Virtual 2020, a conference conducted entirely online. We are pleased to...
  1. 2
  2. 3
  3. 4
  4. 5
  5. 6
  6. 7
  7. 8

Recent Posts

  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast – Episode Library
  • Patient Community Day at ECTRIMS 2025

Recent Comments

  • FDA Decision On Tolebrutinib - MStranslate on Multiple Sclerosis in 2025 – Key Developments to Date
  • Treatment With Gut Bacteria Shows Benefits In New Study on Gut Bacteria in People Living with RRMS
  • Community Q&A: COVID-19 Vaccines & Multiple Sclerosis on Community Q&A: The Blood-Brain Barrier
  • Community Q&A: Why Don't We Have A Multiple Sclerosis Cure? on Community Q&A: COVID-19 Vaccines & MS
  • Tim Little on FAKE NEWS ALERT: COVID Vaccines & MS

Calendar

March 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
« Jan    

Archives

Categories

Posts

  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast – Episode Library
  • Patient Community Day at ECTRIMS 2025

Google+

Get social

Copyright 2014-2018 MStranslate. All Rights Reserved. Contact Us
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.